443 related articles for article (PubMed ID: 17472960)
1. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
4. Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs).
Wu Q; Sun CC; Lin HY; Babitt JL
PLoS One; 2012; 7(9):e46307. PubMed ID: 23029472
[TBL] [Abstract][Full Text] [Related]
5. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.
Babitt JL; Zhang Y; Samad TA; Xia Y; Tang J; Campagna JA; Schneyer AL; Woolf CJ; Lin HY
J Biol Chem; 2005 Aug; 280(33):29820-7. PubMed ID: 15975920
[TBL] [Abstract][Full Text] [Related]
6. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.
Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD
J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551
[TBL] [Abstract][Full Text] [Related]
8. DRAGON, a bone morphogenetic protein co-receptor.
Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
[TBL] [Abstract][Full Text] [Related]
9. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
10. BMP2, BMP4, noggin, BMPRIA, BMPRIB, and BMPRII are differentially expressed in the adult rat spinal cord.
Miyagi M; Mikawa S; Sato T; Hasegawa T; Kobayashi S; Matsuyama Y; Sato K
Neuroscience; 2012 Feb; 203():12-26. PubMed ID: 22202460
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.
Kayani AR; Glister C; Knight PG
Reproduction; 2009 Jan; 137(1):67-78. PubMed ID: 18936084
[TBL] [Abstract][Full Text] [Related]
12. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
14. Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC.
Conrad S; Genth H; Hofmann F; Just I; Skutella T
J Biol Chem; 2007 Jun; 282(22):16423-33. PubMed ID: 17389603
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
16. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor.
Chan MC; Nguyen PH; Davis BN; Ohoka N; Hayashi H; Du K; Lagna G; Hata A
Mol Cell Biol; 2007 Aug; 27(16):5776-89. PubMed ID: 17576816
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
Babitt JL; Huang FW; Wrighting DM; Xia Y; Sidis Y; Samad TA; Campagna JA; Chung RT; Schneyer AL; Woolf CJ; Andrews NC; Lin HY
Nat Genet; 2006 May; 38(5):531-9. PubMed ID: 16604073
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
19. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
Li J; Ye L; Kynaston HG; Jiang WG
Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
[TBL] [Abstract][Full Text] [Related]
20. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
Kudo TA; Kanetaka H; Watanabe A; Okumoto A; Asano M; Zhang Y; Zhao F; Kano M; Shimizu Y; Tamura S; Hayashi H
Tohoku J Exp Med; 2010 Oct; 222(2):121-9. PubMed ID: 20919447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
